AVITA Medical is a global regenerative medicine company committed to providing innovative solutions for skin restoration. They are known for their patented and proprietary platform technology, the RECELL® System, which enables clinicians to rapidly create Spray-On Skin™ Cells using a small sample of the patient's own skin for the treatment of acute thermal burns, full-thickness skin defects, and vitiligo. The company aims to transform the standard of care in wound treatment and skin repigmentation.
The Valencia headquarters serves as the primary operational and commercial hub for the Americas, overseeing sales, marketing, clinical development, regulatory affairs, and administrative functions for its key market.
Located within a modern business park, the facility is equipped with contemporary office amenities conducive to collaboration and supporting the company's commercial and administrative operations.
The work culture at AVITA Medical is likely dynamic, innovative, and patient-centric, fostering collaboration among scientific, commercial, and operational teams dedicated to advancing regenerative medicine.
The US headquarters is strategically important for AVITA Medical's growth, particularly in North America, its largest market. Valencia's proximity to a skilled talent pool and a robust biotech ecosystem further enhances its significance.
AVITA Medical Limited has a growing global presence, with commercial operations and market development activities primarily in North America (USA and Canada), Europe (UK and select EU countries), Australia, and Japan. Its functions supported globally include sales and marketing, clinical research and development, regulatory affairs, manufacturing oversight, and customer support for its RECELL® System.
28159 Avenue Stanford, Suite 220
Valencia
CA
USA
Address: Level 5, 126 Phillip Street, Sydney NSW 2000, Australia
Serves as the official registered entity in Australia and supports regional corporate compliance and historical ties.
Address: St John’s Innovation Centre, Cowley Road, Milton, Cambridge CB4 0WS, UK
Drives commercialization and clinical development efforts across Europe.
Address: AVITA Medical KK, WeWork Shiodome, 1-10-10 Shiodome, Minato-ku, Tokyo 105-0021, Japan
Focused on establishing and expanding AVITA Medical's presence in the Japanese regenerative medicine market.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AVITA Medical' leadership includes:
AVITA Medical has been backed by several prominent investors over the years, including:
AVITA Medical has actively strengthened its executive leadership over the past year with key appointments in commercial, operations, and artificial intelligence, alongside planned transitions in finance and development roles. This reflects a strategic focus on commercial expansion and technological innovation.
Discover the tools AVITA Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Avita Medical Limited likely uses common corporate email formats. Based on standard industry practices, the most probable formats include first initial followed by last name, or first name followed by a dot and then last name.
Common formats: [first_initial][last]@avitamedical.com (e.g., jdoe@avitamedical.com) or [first].[last]@avitamedical.com (e.g., jane.doe@avitamedical.com)
Format
j.doe@avitamedical.com
Example
85%
Success rate
AVITA Medical Investor Relations • May 9, 2024
AVITA Medical announced its financial results for the first quarter ended March 31, 2024, reporting commercial revenue growth and affirming its full-year 2024 financial guidance. The company highlighted continued adoption of the RECELL System....more
WOUNDS Journal / AVITA Medical • March 12, 2024
The company announced the publication of results from its HEAL-C pivotal trial in the peer-reviewed journal WOUNDS, demonstrating the efficacy and safety of the RECELL System in the reconstruction of complex, full-thickness skin defects....more
AVITA Medical Investor Relations • February 27, 2024
AVITA Medical reported its financial results for the fourth quarter and full fiscal year ended December 31, 2023. The company provided an update on its commercial progress and issued guidance for the full year 2024, emphasizing growth initiatives....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AVITA Medical, are just a search away.